From: Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies
Immune-mediated disease (O and E) | All time intervals: rate ratio (95% CI), Pvalue | At least 1 year after admission: rate ratio (95% CI), Pvalue | At least 5 years after admission: rate ratio (95% CI), Pvalue |
---|---|---|---|
Addison’s disease (74, 9.6) | 8.0 (6.3 to 10.1), <0.001 | 10.6 (7.4 to 14.8), <0.001 | 4.7 (2.2 to 8.7), <0.001 |
Ankylosing spondylitis (30, 32.9) | 0.9 (0.6 to 1.3), 0.7 | 1.1 (0.5 to 1.9), 0.9 | 0.9 (0.3 to 1.9), 0.8 |
Autoimmune hemolytic anemia (16, 6.3) | 2.6 (1.5 to 4.2), <0.001 | 2.2 (0.8 to 4.9), 0.1 | 0.7 (0.0 to 3.6), 1 |
Chronic active hepatitis (14, 2.9) | 4.9 (2.6 to 8.2), <0.001 | 2.7 (0.7 to 7.1), 0.1 | 3.7 (0.4 to 13.6), 0.2 |
Crohn’s disease (101, 75.9)a | 1.3 (1.1 to 1.6), 0.005 | 1.0 (0.8 to 1.3), 1.0 | 0.7 (0.4 to 1.2), 0.3 |
Coeliac disease (45, 45.0) | 1.00 (0.7 to 1.3), 0.9 | 1.0 (0.6 to 1.5), 1.0 | 0.7 (0.3 to 1.4), 0.4 |
Dermatomyositis (3, 1.6) | 1.9 (0.4 to 5.5), 0.5 | 4.4 (0.9 to 13.1), 0.03 | 0.0 (0.0 to 9.4), 0.9 |
Polymyositis (10, 3.3) | 3.1 (1.5 to 5.7), 0.001 | 2.3 (0.5 to 6.7), 0.3 | 2.5 (0.3 to 9.0), 0.5 |
Goodpasture’s syndrome (4, 0.8) | 5.1 (1.4 to 13.1), 0.003 | 0.0 (0.0 to 10.4), 0.8 | 0.0 (0.0 to 17.3), 0.5 |
Hashimoto’s thyroiditis (7, 6.1) | 1.2 (0.5 to 2.4), 0.9 | 1.3 (0.3 to 3.8), 0.9 | 0.0 (0.0 to 2.2), 0.4 |
ITP (49, 22.4) | 2.2 (1.6 to 2.9), <0.001 | 2.2 (1.3 to 3.4), 0.001 | 1.7 (0.8 to 3.1), 0.2 |
Multiple sclerosis (17, 49.2) | 0.3 (0.2 to 0.6), <0.001 | 0.7 (0.3 to 1.2), 0.2 | 0.5 (0.2 to 1.2), 0.2 |
Myasthenia gravis (10, 10.1) | 1.0 (0.5 to 1.8), 0.9 | 1.5 (0.6 to 3.3), 0.4 | 0.9 (0.1 to 3.3), 0.9 |
Myxedema (649, 888.8) | 0.7 (0.7 to 0.8), <0.001 | 1.1 (1.0 to 1.2), 0.1 | 0.9 (0.8 to 1.0), 0.2 |
Pemphigus (4, 2.3) | 1.8 (0.5 to 4.5), 0.4 | 0.9 (0.2 to 2.3), 1 | 0.0 (0.0 to 6.1), 0.9 |
Pemphigoid (12, 10.9) | 1.1 (0.6 to 1.9), 0.9 | 1.2 (0.0 to 6.7), 0.7 | 2.1 (0.8 to 4.4), 0.1 |
Pernicious anemia (74, 63.2) | 1.2 (0.9 to 1.5), 0.2 | 1.3 (0.9 to 1.9), 0.2 | 1.3 (0.8 to 2.0), 0.2 |
Polyarteritis nodosa (8, 1.8) | 4.5 (1.9 to 9.0), <0.001 | 8.2 (3.0 to 18.2), <0.001 | 2.1 (0.1 to 11.8), 1.0 |
Primary biliary cirrhosis (13, 8.0) | 1.6 (0.9 to 2.8), 0.1 | 1.8 (0.7 to 4.0), 0.2 | 1.0 (0.1 to 3.5), 0.8 |
Psoriasis (108, 119.9) | 0.9 (0.7 to 1.1), 0.3 | 1.4 (1.0 to 1.8), 0.04 | 0.9 (0.5 to 1.3), 0.5 |
Rheumatoid arthritis (259, 271.8)b | 0.9 (0.8 to 1.1), 0.5 | 1.1 (1.0 to 1.3), 0.1 | 1.0 (0.7 to 1.2), 0.8 |
Scleroderma (14, 8.8) | 1.6 (0.9 to 2.7), 0.1 | 1.1 (0.3 to 2.9), 1 | 1.6 (0.4 to 4.2), 0.5 |
Sjögren’s syndrome (35, 17.8) | 2.0 (1.4 to 2.8), <0.001 | 2.1 (1.2 to 3.6), <0.001 | 2.6 (1.4 to 4.6), <0.001 |
SLE (82, 23.2) | 3.6 (2.9 to 4.5), <0.001 | 4.4 (3.1 to 6.0), <0.001 | 2.5 (1.3 to 4.3). <0.001 |
Thyrotoxicosis (141, 117.1) | 1.2 (1.0 to 1.4), 0.03 | 1.5 (1.2 to 1.9), <0.001 | 1.1 (0.8 to 1.6), 0.5 |
Ulcerative colitis (106, 121.8) | 0.9 (0.7 to 1.1), 0.2 | 0.9 (0.7 to 1.2), 0.5 | 0.9 (0.6 to 1.3), 0.6 |